- Home
- Publications
- Publication Search
- Publication Details
Title
What are the drugs having potential against COVID-19?
Authors
Keywords
-
Journal
MEDICINAL CHEMISTRY RESEARCH
Volume 29, Issue 11, Pages 1935-1955
Publisher
Springer Science and Business Media LLC
Online
2020-09-10
DOI
10.1007/s00044-020-02625-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Recent discovery and development of inhibitors targeting coronaviruses
- (2020) Thanigaimalai Pillaiyar et al. DRUG DISCOVERY TODAY
- COVID-19 in Singapore—Current Experience
- (2020) John E. L. Wong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Potential interventions for novel coronavirus in China: A systematic review
- (2020) Lei Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Recent advances in the detection of respiratory virus infection in humans
- (2020) Naru Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019
- (2020) Wenzheng Han et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
- (2020) Emmie de Wit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
- (2020) Xintian Xu et al. Science China-Life Sciences
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
- (2020) Timothy P. Sheahan et al. Nature Communications
- The Emerging Role of Vitamin C as a Treatment for Sepsis
- (2020) Markos G. Kashiouris et al. Nutrients
- Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
- (2020) Xiao-Wei Xu et al. BMJ-British Medical Journal
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics
- (2020) Jinnong Zhang et al. Lancet Respiratory Medicine
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
- (2020) Christian A. Devaux et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
- (2020) Jacques Fantini et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Coronavirus disease 2019 (COVID-19): current status and future perspectives
- (2020) Heng Li et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment
- (2020) Zhenwei Wang et al. BioScience Trends
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
- (2020) Abdo A. Elfiky LIFE SCIENCES
- From SARS to MERS, Thrusting Coronaviruses into the Spotlight
- (2019) Zhiqi Song et al. Viruses-Basel
- Bats and Coronaviruses
- (2019) Arinjay Banerjee et al. Viruses-Basel
- Simplification of Antiretroviral Treatment from Darunavir/Ritonavir Monotherapy to Darunavir/Cobicistat Monotherapy: Effectiveness and Safety in Routine Clinical Practice
- (2019) José Ramón Santos et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Coronavirus envelope protein: current knowledge
- (2019) Dewald Schoeman et al. Virology Journal
- Two Ebola treatments halve deaths in trial in DRC outbreak
- (2019) Owen Dyer BMJ-British Medical Journal
- Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
- (2018) Leen Delang et al. ANTIVIRAL RESEARCH
- Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016
- (2018) A. Bleibtreu et al. BMC INFECTIOUS DISEASES
- Oseltamivir Treatment of Influenza in Children
- (2018) Timothy M Uyeki CLINICAL INFECTIOUS DISEASES
- Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission
- (2018) David S Hui et al. LANCET INFECTIOUS DISEASES
- Natural killer cell specificity for viral infections
- (2018) Quirin Hammer et al. NATURE IMMUNOLOGY
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- Molecular Basis for the Recognition of Herpes Simplex Virus Type 1 Infection by Human Natural Killer Cells
- (2018) Hong-Sheng Dai et al. Frontiers in Immunology
- Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review
- (2018) Sabeena Mustafa et al. Journal of Infection and Public Health
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Management of adverse events in the treatment of patients with immunoglobulin therapy: A review of evidence
- (2016) Patrick Cherin et al. AUTOIMMUNITY REVIEWS
- Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
- (2016) Jaffar A. Al-Tawfiq et al. Expert Review of Anti-Infective Therapy
- The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses
- (2016) Eve-Isabelle Pécheur et al. JOURNAL OF VIROLOGY
- Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion
- (2016) Christopher M. Coleman et al. JOURNAL OF VIROLOGY
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea
- (2016) Johan van Griensven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome: a case report
- (2015) Uh Jin Kim et al. ANTIVIRAL THERAPY
- MERS in South Korea and China: a potential outbreak threat?
- (2015) Shuo Su et al. LANCET
- Middle East respiratory syndrome
- (2015) Alimuddin Zumla et al. LANCET
- The structure and functions of coronavirus genomic 3′ and 5′ ends
- (2015) Dong Yang et al. VIRUS RESEARCH
- Systemic cyclosporine and corneal transplantation
- (2015) Mohammed Ziaei et al. INTERNATIONAL OPHTHALMOLOGY
- Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
- (2015) Yaseen Arabi et al. SpringerPlus
- Interferon-Stimulated Genes: A Complex Web of Host Defenses
- (2014) William M. Schneider et al. Annual Review of Immunology
- Arbidol as a broad-spectrum antiviral: An update
- (2014) Julie Blaising et al. ANTIVIRAL RESEARCH
- A decade after SARS: strategies for controlling emerging coronaviruses
- (2013) Rachel L. Graham et al. NATURE REVIEWS MICROBIOLOGY
- Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model
- (2012) Yiwu Yan et al. CELL RESEARCH
- The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
- (2011) Susanne Pfefferle et al. PLoS Pathogens
- Mesenchymal stem cells for acute lung injury: Preclinical evidence
- (2010) Michael A. Matthay et al. CRITICAL CARE MEDICINE
- Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-Induced Lung Injury
- (2009) Yuben Moodley et al. AMERICAN JOURNAL OF PATHOLOGY
- Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity
- (2009) A A Mathias et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
- (2009) M. Kumamoto et al. EUROPEAN RESPIRATORY JOURNAL
- Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation
- (2009) T. Kuri et al. JOURNAL OF GENERAL VIROLOGY
- The management of coronavirus infections with particular reference to SARS
- (2008) S. S. Y. Wong et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now